Skip to main content
Figure 4 | BMC Gastroenterology

Figure 4

From: Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: A monocentric cohort study in China

Figure 4

Distribution of serum TFF3 in differentiated or undifferentiated, early or advanced gastric cancer. The concentration of serum TFF3 in patients with differentiated gastric cancer was significantly lower than in undifferentiated group (P = 0.0273). Serum TFF3 level in patients with early gastric cancer was also significantly lower than in advanced gastric cancer (P = 0.0497). The results showed that the concentration of serum TFF3 has correlated with histological type and TNM stages of gastric cancer.

Back to article page